<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Adverse Events by System Organ Class and Dictionary-Derived Term Table — aet02_2 • chevron</title>


<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous" />


<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="Adverse Events by System Organ Class and Dictionary-Derived Term Table — aet02_2" />
<meta property="og:description" content="The AET02_2 table provides an overview of the number of patients experiencing advert events and the number of advert
events categorized by Body System, High Level Term and Dictionary-Derived Term." />




<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body data-spy="scroll" data-target="#toc">
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">chevron</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.1.0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fas fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../articles/chevron.html">Get started</a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/insightsengineering/chevron">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Adverse Events by System Organ Class and Dictionary-Derived Term Table</h1>
    
    <div class="hidden name"><code>aet02_2.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>The AET02_2 table provides an overview of the number of patients experiencing advert events and the number of advert
events categorized by Body System, High Level Term and Dictionary-Derived Term.</p>
    </div>

    <pre class="usage"><span class='fu'>aet02_2</span><span class='op'>(</span>
  <span class='va'>adsl</span>,
  <span class='va'>adae</span>,
  armvar <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>armvar</span>,
  lbl_overall <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>lbl_overall</span>,
  prune_0 <span class='op'>=</span> <span class='cn'>TRUE</span>,
  deco <span class='op'>=</span> <span class='fu'><a href='std_deco.html'>std_deco</a></span><span class='op'>(</span><span class='st'>"AET02"</span><span class='op'>)</span>,
  .study <span class='op'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/list.html'>list</a></span><span class='op'>(</span>armvar <span class='op'>=</span> <span class='st'>"ACTARM"</span>, lbl_overall <span class='op'>=</span> <span class='st'>""</span><span class='op'>)</span>
<span class='op'>)</span></pre>

    <h2 class="hasAnchor" id="arguments"><a class="anchor" href="#arguments"></a>Arguments</h2>
    <table class="ref-arguments">
    <colgroup><col class="name" /><col class="desc" /></colgroup>
    <tr>
      <th>adsl</th>
      <td><p>Subject Level Analysis Dataset</p></td>
    </tr>
    <tr>
      <th>adae</th>
      <td><p>Adverse Events Analysis Dataset</p></td>
    </tr>
    <tr>
      <th>armvar</th>
      <td><p>variable used for column splitting</p></td>
    </tr>
    <tr>
      <th>lbl_overall</th>
      <td><p>label used for overall column, if set to <code>NULL</code> the overall column is omitted</p></td>
    </tr>
    <tr>
      <th>prune_0</th>
      <td><p>remove 0 count rows</p></td>
    </tr>
    <tr>
      <th>deco</th>
      <td><p>decoration list with <code>title</code>, <code>subtitles</code> and <code>main_footer</code> content</p></td>
    </tr>
    <tr>
      <th>.study</th>
      <td><p>a list with default values for the arguments of the function</p></td>
    </tr>
    </table>

    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    
<ul>
<li><p>Numbers represent absolute numbers of patients and fraction of <code>N</code>, or absolute number of event when specified.</p></li>
<li><p>Remove zero-count rows unless overridden with <code>prune_0 = FALSE</code>.</p></li>
<li><p>Split columns by arm.</p></li>
<li><p>Does not include a total column by default.</p></li>
<li><p>Sort Body System or Organ Class, High Level Term and Dictionary-Derived Term hierarchically by highest overall frequencies.</p></li>
</ul>


    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><div class='input'><span class='kw'><a href='https://rdrr.io/r/base/library.html'>library</a></span><span class='op'>(</span><span class='va'>scda</span><span class='op'>)</span>
<span class='kw'><a href='https://rdrr.io/r/base/library.html'>library</a></span><span class='op'>(</span><span class='va'><a href='https://dplyr.tidyverse.org'>dplyr</a></span><span class='op'>)</span>
<span class='va'>sd</span> <span class='op'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/pkg/scda/man/synthetic_cdisc_data.html'>synthetic_cdisc_data</a></span><span class='op'>(</span><span class='st'>"rcd_2021_03_22"</span><span class='op'>)</span>
<span class='va'>adsl</span> <span class='op'>&lt;-</span> <span class='va'>sd</span><span class='op'>$</span><span class='va'>adsl</span>
<span class='va'>adae</span> <span class='op'>&lt;-</span> <span class='va'>sd</span><span class='op'>$</span><span class='va'>adae</span> <span class='op'>%&gt;%</span>
 <span class='fu'><a href='https://dplyr.tidyverse.org/reference/mutate.html'>mutate</a></span><span class='op'>(</span>ANL01FL <span class='op'>=</span> <span class='st'>'Y'</span><span class='op'>)</span>

<span class='fu'>aet02_2</span><span class='op'>(</span><span class='va'>adsl</span>, <span class='va'>adae</span><span class='op'>)</span>
</div><div class='output co'>#&gt; Body System or Organ Class                                                                              
#&gt;   High Level Term                                              A: Drug X    B: Placebo    C: Combination
#&gt;  Dictionary-Derived Term                                        (N=134)       (N=134)        (N=132)    
#&gt; --------------------------------------------------------------------------------------------------------
#&gt; Total number of patients with at least one adverse event       122 (91%)    123 (91.8%)    120 (90.9%)  
#&gt; Overall total number of events                                    609           622            703      
#&gt; cl A.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event     78 (58.2%)    75 (56%)       89 (67.4%)  
#&gt;   Total number of events                                          132           130            160      
#&gt;   hlt A.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)  
#&gt;     Total number of events                                        132           130            160      
#&gt;     dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)  
#&gt;     dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)  
#&gt; cl B.2                                                                                                  
#&gt;   Total number of patients with at least one adverse event      79 (59%)    74 (55.2%)      85 (64.4%)  
#&gt;   Total number of events                                          129           138            143      
#&gt;   hlt B.2.2.3                                                                                           
#&gt;     Total number of patients with at least one adverse event   48 (35.8%)   54 (40.3%)      51 (38.6%)  
#&gt;     Total number of events                                         64           76              77      
#&gt;     dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)  
#&gt;   hlt B.2.1.2                                                                                           
#&gt;     Total number of patients with at least one adverse event   49 (36.6%)   44 (32.8%)      52 (39.4%)  
#&gt;     Total number of events                                         65           62              66      
#&gt;     dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)  
#&gt; cl D.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event      79 (59%)     67 (50%)       80 (60.6%)  
#&gt;   Total number of events                                          127           106            135      
#&gt;   hlt D.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   50 (37.3%)   42 (31.3%)      51 (38.6%)  
#&gt;     Total number of events                                         61           51              71      
#&gt;     dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)  
#&gt;   hlt D.1.1.4                                                                                           
#&gt;     Total number of patients with at least one adverse event   48 (35.8%)   42 (31.3%)      50 (37.9%)  
#&gt;     Total number of events                                         66           55              64      
#&gt;     dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)  
#&gt; cl D.2                                                                                                  
#&gt;   Total number of patients with at least one adverse event     47 (35.1%)   58 (43.3%)      57 (43.2%)  
#&gt;   Total number of events                                           62           72              74      
#&gt;   hlt D.2.1.5                                                                                           
#&gt;     Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)  
#&gt;     Total number of events                                         62           72              74      
#&gt;     dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)  
#&gt; cl B.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event     47 (35.1%)   49 (36.6%)      43 (32.6%)  
#&gt;   Total number of events                                           56           60              62      
#&gt;   hlt B.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)  
#&gt;     Total number of events                                         56           60              62      
#&gt;     dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)  
#&gt; cl C.2                                                                                                  
#&gt;   Total number of patients with at least one adverse event     35 (26.1%)   48 (35.8%)      55 (41.7%)  
#&gt;   Total number of events                                           48           53              65      
#&gt;   hlt C.2.1.2                                                                                           
#&gt;     Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)  
#&gt;     Total number of events                                         48           53              65      
#&gt;     dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)  
#&gt; cl C.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event     43 (32.1%)   46 (34.3%)      43 (32.6%)  
#&gt;   Total number of events                                           55           63              64      
#&gt;   hlt C.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)  
#&gt;     Total number of events                                         55           63              64      
#&gt;     dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)  
#&gt; --------------------------------------------------------------------------------------------------------
#&gt; 
#&gt; Footnotes go here</div><div class='input'><span class='fu'>aet02_2</span><span class='op'>(</span><span class='va'>adsl</span>, <span class='va'>adae</span>, lbl_overall <span class='op'>=</span> <span class='st'>"All Patients"</span><span class='op'>)</span>
</div><div class='output co'>#&gt; Main Title
#&gt; Protocol: {{protocol}}, Snapshot: {{snapshot}}, Snapshot Date: {{snapshot-date}}, Cutoff Date: {{cutoff-date}}
#&gt; 
#&gt; -----------------------------------------------------------------------------------------------------------------------
#&gt; Body System or Organ Class                                                                                             
#&gt;   High Level Term                                              A: Drug X    B: Placebo    C: Combination   All Patients
#&gt;  Dictionary-Derived Term                                        (N=134)       (N=134)        (N=132)         (N=400)   
#&gt; -----------------------------------------------------------------------------------------------------------------------
#&gt; Total number of patients with at least one adverse event       122 (91%)    123 (91.8%)    120 (90.9%)     365 (91.2%) 
#&gt; Overall total number of events                                    609           622            703             1934    
#&gt; cl A.1                                                                                                                 
#&gt;   Total number of patients with at least one adverse event     78 (58.2%)    75 (56%)       89 (67.4%)     242 (60.5%) 
#&gt;   Total number of events                                          132           130            160             422     
#&gt;   hlt A.1.1.1                                                                                                          
#&gt;     Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)     242 (60.5%) 
#&gt;     Total number of events                                        132           130            160             422     
#&gt;     dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)     158 (39.5%) 
#&gt;     dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)     146 (36.5%) 
#&gt; cl B.2                                                                                                                 
#&gt;   Total number of patients with at least one adverse event      79 (59%)    74 (55.2%)      85 (64.4%)     238 (59.5%) 
#&gt;   Total number of events                                          129           138            143             410     
#&gt;   hlt B.2.2.3                                                                                                          
#&gt;     Total number of patients with at least one adverse event   48 (35.8%)   54 (40.3%)      51 (38.6%)     153 (38.2%) 
#&gt;     Total number of events                                         64           76              77             217     
#&gt;     dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)     153 (38.2%) 
#&gt;   hlt B.2.1.2                                                                                                          
#&gt;     Total number of patients with at least one adverse event   49 (36.6%)   44 (32.8%)      52 (39.4%)     145 (36.2%) 
#&gt;     Total number of events                                         65           62              66             193     
#&gt;     dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)     145 (36.2%) 
#&gt; cl D.1                                                                                                                 
#&gt;   Total number of patients with at least one adverse event      79 (59%)     67 (50%)       80 (60.6%)     226 (56.5%) 
#&gt;   Total number of events                                          127           106            135             368     
#&gt;   hlt D.1.1.1                                                                                                          
#&gt;     Total number of patients with at least one adverse event   50 (37.3%)   42 (31.3%)      51 (38.6%)     143 (35.8%) 
#&gt;     Total number of events                                         61           51              71             183     
#&gt;     dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)     143 (35.8%) 
#&gt;   hlt D.1.1.4                                                                                                          
#&gt;     Total number of patients with at least one adverse event   48 (35.8%)   42 (31.3%)      50 (37.9%)      140 (35%)  
#&gt;     Total number of events                                         66           55              64             185     
#&gt;     dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)      140 (35%)  
#&gt; cl D.2                                                                                                                 
#&gt;   Total number of patients with at least one adverse event     47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
#&gt;   Total number of events                                           62           72              74             208     
#&gt;   hlt D.2.1.5                                                                                                          
#&gt;     Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
#&gt;     Total number of events                                         62           72              74             208     
#&gt;     dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
#&gt; cl B.1                                                                                                                 
#&gt;   Total number of patients with at least one adverse event     47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
#&gt;   Total number of events                                           56           60              62             178     
#&gt;   hlt B.1.1.1                                                                                                          
#&gt;     Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
#&gt;     Total number of events                                         56           60              62             178     
#&gt;     dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
#&gt; cl C.2                                                                                                                 
#&gt;   Total number of patients with at least one adverse event     35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
#&gt;   Total number of events                                           48           53              65             166     
#&gt;   hlt C.2.1.2                                                                                                          
#&gt;     Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
#&gt;     Total number of events                                         48           53              65             166     
#&gt;     dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
#&gt; cl C.1                                                                                                                 
#&gt;   Total number of patients with at least one adverse event     43 (32.1%)   46 (34.3%)      43 (32.6%)      132 (33%)  
#&gt;   Total number of events                                           55           63              64             182     
#&gt;   hlt C.1.1.1                                                                                                          
#&gt;     Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)      132 (33%)  
#&gt;     Total number of events                                         55           63              64             182     
#&gt;     dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)      132 (33%)  
#&gt; -----------------------------------------------------------------------------------------------------------------------
#&gt; 
#&gt; Footnotes go here</div><div class='input'>
<span class='va'>adae</span> <span class='op'>&lt;-</span> <span class='va'>adae</span> <span class='op'>%&gt;%</span> <span class='fu'>var_relabel</span><span class='op'>(</span>AEBODSYS <span class='op'>=</span> <span class='st'>"Medra System Organ Class"</span><span class='op'>)</span>
<span class='fu'>aet02_2</span><span class='op'>(</span><span class='va'>adsl</span>, <span class='va'>adae</span><span class='op'>)</span>
</div><div class='output co'>#&gt; Medra System Organ Class                                                                                
#&gt;   High Level Term                                              A: Drug X    B: Placebo    C: Combination
#&gt;  Dictionary-Derived Term                                        (N=134)       (N=134)        (N=132)    
#&gt; --------------------------------------------------------------------------------------------------------
#&gt; Total number of patients with at least one adverse event       122 (91%)    123 (91.8%)    120 (90.9%)  
#&gt; Overall total number of events                                    609           622            703      
#&gt; cl A.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event     78 (58.2%)    75 (56%)       89 (67.4%)  
#&gt;   Total number of events                                          132           130            160      
#&gt;   hlt A.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)  
#&gt;     Total number of events                                        132           130            160      
#&gt;     dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)  
#&gt;     dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)  
#&gt; cl B.2                                                                                                  
#&gt;   Total number of patients with at least one adverse event      79 (59%)    74 (55.2%)      85 (64.4%)  
#&gt;   Total number of events                                          129           138            143      
#&gt;   hlt B.2.2.3                                                                                           
#&gt;     Total number of patients with at least one adverse event   48 (35.8%)   54 (40.3%)      51 (38.6%)  
#&gt;     Total number of events                                         64           76              77      
#&gt;     dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)  
#&gt;   hlt B.2.1.2                                                                                           
#&gt;     Total number of patients with at least one adverse event   49 (36.6%)   44 (32.8%)      52 (39.4%)  
#&gt;     Total number of events                                         65           62              66      
#&gt;     dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)  
#&gt; cl D.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event      79 (59%)     67 (50%)       80 (60.6%)  
#&gt;   Total number of events                                          127           106            135      
#&gt;   hlt D.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   50 (37.3%)   42 (31.3%)      51 (38.6%)  
#&gt;     Total number of events                                         61           51              71      
#&gt;     dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)  
#&gt;   hlt D.1.1.4                                                                                           
#&gt;     Total number of patients with at least one adverse event   48 (35.8%)   42 (31.3%)      50 (37.9%)  
#&gt;     Total number of events                                         66           55              64      
#&gt;     dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)  
#&gt; cl D.2                                                                                                  
#&gt;   Total number of patients with at least one adverse event     47 (35.1%)   58 (43.3%)      57 (43.2%)  
#&gt;   Total number of events                                           62           72              74      
#&gt;   hlt D.2.1.5                                                                                           
#&gt;     Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)  
#&gt;     Total number of events                                         62           72              74      
#&gt;     dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)  
#&gt; cl B.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event     47 (35.1%)   49 (36.6%)      43 (32.6%)  
#&gt;   Total number of events                                           56           60              62      
#&gt;   hlt B.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)  
#&gt;     Total number of events                                         56           60              62      
#&gt;     dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)  
#&gt; cl C.2                                                                                                  
#&gt;   Total number of patients with at least one adverse event     35 (26.1%)   48 (35.8%)      55 (41.7%)  
#&gt;   Total number of events                                           48           53              65      
#&gt;   hlt C.2.1.2                                                                                           
#&gt;     Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)  
#&gt;     Total number of events                                         48           53              65      
#&gt;     dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)  
#&gt; cl C.1                                                                                                  
#&gt;   Total number of patients with at least one adverse event     43 (32.1%)   46 (34.3%)      43 (32.6%)  
#&gt;   Total number of events                                           55           63              64      
#&gt;   hlt C.1.1.1                                                                                           
#&gt;     Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)  
#&gt;     Total number of events                                         55           63              64      
#&gt;     dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)  
#&gt; --------------------------------------------------------------------------------------------------------
#&gt; 
#&gt; Footnotes go here</div><div class='input'>
</div></pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by NEST, Roche, Adrian Waddell, Benoit Falquet.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.6.1.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


